Osteopontin (OPN) expression in thyroid carcinoma.

Anticancer Res

Department of Laboratory Medicine and Pathobiology, University of Toronto, Department of Pathology, University Health Network, and Ontario Cancer Institute, Toronto, Ontario, Canada.

Published: May 2010

Background: Osteopontin (OPN) and its interacting partner CEA-cell adhesion molecule (CEACAM1) mediate similar biological functions and have been expressed in several types of cancer. Here we investigated the prognostic significance of OPN in thyroid tumours and correlated our findings with the expression of CEACAM1.

Materials And Methods: 297 human thyroid samples were collected in a tissue microarray and as fresh frozen samples to perform immunohistochemistry and western blotting for OPN and to compare these data with our previously published data on CEACAM1 expression.

Results: Nearly all normal samples were negative for OPN. Some thyroid adenomas were weakly OPN positive whereas many carcinomas were strongly positive. In contrast to CEACAM1, which was preferentially expressed in metastatic papillary carcinomas, no associations were found between OPN expression and patient age, gender and tumour size.

Conclusion: These results may have future implications for the diagnosis and management of patients with thyroid cancers.

Download full-text PDF

Source

Publication Analysis

Top Keywords

osteopontin opn
8
opn expression
8
opn thyroid
8
opn
6
thyroid
5
expression thyroid
4
thyroid carcinoma
4
carcinoma background
4
background osteopontin
4
opn interacting
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!